In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell lines. [electronic resource]
Producer: 20120611Description: 480-9 p. digitalISSN:- 1573-0646
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Boronic Acids -- pharmacology
- Bortezomib
- Caspase 3 -- metabolism
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Dose-Response Relationship, Drug
- Drug Synergism
- Flow Cytometry
- HL-60 Cells
- Humans
- Immunohistochemistry
- Inhibitory Concentration 50
- K562 Cells
- Ki-67 Antigen -- metabolism
- Lenalidomide
- Leukemia, Myeloid -- metabolism
- Lymphoma -- metabolism
- Multiple Myeloma -- metabolism
- Phosphorylcholine -- analogs & derivatives
- Pyrazines -- pharmacology
- Thalidomide -- analogs & derivatives
- Time Factors
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.